Changes in Hong Kong stocks | True Healthcare-B (02697) rose more than 6% in the afternoon, and the company signed a sales contract of nearly 100 million yuan for puncture navigation and positioning systems

The Zhitong Finance App learned that True Healthcare-B (02697) rose more than 6% in the afternoon. As of press release, it had risen 5.79% to HK$666.5, with a turnover of HK$145.251 million.

According to the news, on August 31, True Health Medical announced that the company has signed a sales contract with an independent third party to sell puncture navigation and positioning systems to the buyer. The total contract amount is close to RMB 100 million, and related products will be delivered one after another in the near future. Industry analysts believe that the execution of the nearly 100 million yuan contract will not only provide new support for True Health Care to continue to expand medical institution customers, increase market coverage, and accelerate large-scale business development, but also once again set a new benchmark for the development of the percutaneous surgical robot segment.

It is worth noting that True Health recently released its first interim results after launch. It achieved revenue of 5.671 million yuan in the first half of the year, an increase of nearly 32 times over the previous year. Among them, surgical robots accounted for 91.0% of sales revenue, and consumables revenue increased 135.8% year on year. The “equipment+consumables” business model has been implemented, and the flywheel that drives consumables is spinning at an accelerated pace. The batch delivery of this order will inject more momentum into this model.